Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Saved in:
Bibliographic Details
Main Authors: Goldschmidt, Hartmut (Author) , Sonneveld, P. (Author) , Cremer, Friedrich Walter (Author) , Holt, B. van der (Author) , Westveer, P. (Author) , Breitkreutz, Iris (Author) , Benner, Axel (Author) , Glasmacher, A. (Author) , Schmidt-Wolf, I. G. D. (Author) , Martin, H. (Author) , Hoelzer, D. (Author) , Ho, Anthony Dick (Author) , Lokhorst, H. M. (Author)
Format: Article (Journal)
Language:English
Published: 4 July 2003
In: Annals of hematology
Year: 2003, Volume: 82, Issue: 10, Pages: 654-659
ISSN:1432-0584
DOI:10.1007/s00277-003-0685-2
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-003-0685-2
Get full text
Author Notes:H. Goldschmidt, P. Sonneveld, F.W. Cremer, B. van der Holt, P. Westveer, I. Breitkreutz, A. Benner, A. Glasmacher, I. G.D. Schmidt-Wolf, H. Martin, D. Hoelzer, A.D. Ho, H.M. Lokhorst
Description
Item Description:Gesehen am 11.02.2022
Physical Description:Online Resource
ISSN:1432-0584
DOI:10.1007/s00277-003-0685-2